(Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming TD Cowen 45th Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback